Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
OXGN vs. ETF Alternatives
OxiGene Inc is a biopharmaceutical company. The Company is engaged in development of vascular disrupting agents (VDAs) for the treatment of cancer. Ithas two clinical stage product candidates that are developed in three potential oncology indications.
Other News & PR